MEDIASTINAL LARGE B CELL LYMPHOMA
Clinical trials for MEDIASTINAL LARGE B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MEDIASTINAL LARGE B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for MEDIASTINAL LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with different types of blood cancers like lymphoma and leukemia. The main goal was to check safety and see how well the treatment works. This is an early-stage study, so results help gui…
Matched conditions: MEDIASTINAL LARGE B CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 17, 2026 04:33 UTC
-
New radiation schedule aims to ease path to CAR t for lymphoma patients
Disease control CompletedThis study tested a new radiation therapy schedule for people with B-cell lymphoma that has come back or not responded to treatment. Participants received radiation once a week for five weeks before their CAR T-cell therapy. The goal was to see if this schedule makes radiation ea…
Matched conditions: MEDIASTINAL LARGE B CELL LYMPHOMA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 13, 2026 16:02 UTC